Zuellig Pharma announces investment in HBC for develope medical claims solution in Thailand

Zuellig Pharma

Zuellig Pharma, the region’s leading healthcare services provider, signed an agreement to invest in Health Benefit Consultants Company (HBC) through its Malaysian subsidiary – MiCare Sdn Bhd.

HBC is a leading third party administrator in Thailand providing medical claims administration and related consulting and advisory services to corporates and insurance companies.

This partnership will focus on growing HBC in Thailand and expanding the services and health benefits it offers to Thai people. Meanwhile, HBC will have access to MiCare’s global network, providing it with greater business expansion opportunity.

Related Posts